Influence of a novel electrocardiogram-synchronized rotational-speed-change system of an implantable continuous-flow left ventricular assist device (EVAHEART) on hemolytic performance
- 301 Downloads
We developed a novel controller for a continuous-flow left ventricular assist device (EVAHEART) that can change the pump’s rotational speed (RS) in synchronization with a patient’s myocardial electrocardiogram (ECG) with the aim of facilitating cardiac recovery. We previously presented various applications of this system in animal models, but there remained a concern that the repeated acceleration and deceleration of the impeller may induce additional hemolysis. In this study, we evaluated the blood trauma and motor power consumption induced by our system in a mock circulation. We evaluated our system with a 60-bpm pulse frequency and a variance between the high and low RSs of 500 rpm (EVA-P; n = 4). The continuous modes of EVAHEART (EVA-C; n = 4) and ROTAFLOW (n = 4) were used as controls. The pumps were examined at a mean flow rate of 5.0 ± 0.2 L/min against a mean pressure head of 100 ± 3 mmHg for a 4-h period. As a result, the normalized indexes of the hemolysis levels of EVA-P and EVA-C were 0.0023 ± 0.0019 and 0.0023 ± 0.0025, respectively, and their difference was not significant. The estimated mean motor power consumptions of EVA-C and EVA-P were 6.24 ± 0.33 and 7.19 ± 0.93 W, respectively. When a novel ECG-synchronized RS-change system was applied to EVAHEART, the periodic RS change with a 500-rpm RS variance did not affect the hemolysis at a 60-bpm pulse frequency.
KeywordsHemolytic performance Implantable left ventricular assist devices Pulsatile flow EVAHEART Electrocardiogram-synchronized rotational-speed-change system
Conflict of interests
The authors have no conflicts of interest to disclose.
- 4.Umeki A, Nishimura T, Ando M, Takewa Y, Yamazaki K, Kyo S, et al. Change of coronary flow by continuous-flow left ventricular assist device with cardiac beat synchronizing system (native heart load control system) in acute ischemic heart failure model. Circ J. 2013;77:995–1000.PubMedCrossRefGoogle Scholar
- 5.Umeki A, Nishimura T, Ando M, Takewa Y, Yamazaki K, Kyo S, et al. Alteration of LV end-diastolic volume by controlling the power of the continuous-flow LVAD, so it is synchronized with cardiac beat: development of a native heart load control system (NHLCS). J Artif Organs. 2012;15:128–33.PubMedCrossRefGoogle Scholar
- 6.Arakawa M, Nishimura T, Takewa Y, Umeki A, Ando M, Adachi H, et al. Alternation of left ventricular load by a continuous-flow left ventricular assist device with a native heart load control system in a chronic heart failure model. J Thorac Cardiovasc Surg. 2014. doi: 10.1016/j.jtcvs.2013.12.049. (Epub ahead of print).
- 9.ASTM. ASTM F1841-91. Standard practice for assessment of hemolysis in continuous flow blood pumps. 2005.Google Scholar
- 11.Araki K, Taenaka Y, Masuzawa T, Wakisaka Y, Nakatani T, Akagi H, et al. In vitro performance in centrifugal blood pumps. Jpn J Artif Organs. 1994;23:898–903.Google Scholar
- 12.Tayama E, Nakazawa T, Takami Y, Ohtsubo S, Ohbayashi Y, Andrade AJ, et al. The hemolysis test of Gyro C1E3 pump in pulsatile mode. Artif Organs. 1997;21:657–9.Google Scholar